While C-19 has taken a toll on near-term earnings, it has necessitated actions to reduce costs and eliminate non-core activities, setting the business up well for a more positive environment. The better than expected balance sheet position at June trumps our lower earnings forecasts and we maintain a BUY call on a $0.42 valuation (priorRead more
Argonaut | The Natural Choice in Resources.
© 2024 Argonaut.